Katayama Seiji, Ae Nobuyuki, Kodo Toru, Masumoto Shuji, Hourai Shinji, Tamamura Chika, Tanaka Hiroyasu, Nagata Ryu
Research Division, Sumitomo Pharmaceuticals Co., Ltd, 1-98 Kasugadenaka 3-chome, Konohana-ku, Osaka 554-0022, Japan.
J Med Chem. 2003 Feb 27;46(5):691-701. doi: 10.1021/jm020239l.
A series of tricyclic indole-2-carboxylic acid derivatives were synthesized and evaluated by the radioligand binding assay and the anticonvulsant effects in the mouse NMDA-induced seizure model. Among them, derivatives of 3S-(-)-4 such as 3a, 3f, and 3g which had certain zwitterionic anilides showed high affinity to the NMDA-glycine binding site. The absolute configuration of 3S-(-)-4 was confirmed by X-ray crystallographic analysis. In particular, 3g (SM-31900) was found to be a highly active glycine antagonist for both in vitro and in vivo assays (K(i) = 1.0 +/- 0.1 nM, ED(50) = 2.3 mg/kg, iv) and also showed high selectivity for the glycine site. In addition, 3g was soluble enough in aqueous media (>10 mg/mL at pH 7.4) to use for medications by intravenous injection.
合成了一系列三环吲哚 -2- 羧酸衍生物,并通过放射性配体结合试验和小鼠 NMDA 诱导的癫痫模型中的抗惊厥作用进行评估。其中,具有一定两性离子苯胺类的 3S-(-)-4 的衍生物,如 3a、3f 和 3g,对 NMDA - 甘氨酸结合位点表现出高亲和力。通过 X 射线晶体学分析确定了 3S-(-)-4 的绝对构型。特别地,发现 3g(SM - 31900)在体外和体内试验中都是一种高活性的甘氨酸拮抗剂(K(i) = 1.0 +/- 0.1 nM,ED(50) = 2.3 mg/kg,静脉注射),并且对甘氨酸位点也表现出高选择性。此外,3g 在水性介质中具有足够的溶解性(在 pH 7.4 时>10 mg/mL),可用于静脉注射给药。